NHS drug

AI technology predicts bowel cancer patient responses to new NHS drug

by
A group of healthcare professionals discusses patient data and treatment plans in a hospital setting, highlighting the integration of AI technology in predicting responses to a new bowel cancer drug.

In a pilot study launched in early 2023, researchers at several NHS hospitals began utilizing machine learning algorithms to analyze patient data. These algorithms assess various factors, including genetic information and previous treatment responses, to forecast individual reactions to the innovative drug. The results from this study could significantly influence treatment plans for thousands of … Read more